Download Free Sample Report

The global Interventional Oncology Device market was valued at US$ 3.36 billion in 2023 and is projected to reach US$ 5.50 billion by 2030, at a CAGR of 7.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Interventional Oncology Device refers to theOncology, like internal medicine, surgery, obstetrics and gynecology, and pediatrics, is a secondary discipline of clinical medicine. It is divided into oncology, oncology radiotherapy, and oncology surgery. Oncology is mainly engaged in medical treatment of various benign and malignant tumors; The Department of Radiation Oncology is mainly engaged in radiotherapy of tumors; oncology surgery provides surgery-based comprehensive treatment. Relevant departments of specialized cancer hospitals will be subdivided according to different parts, such as gastrointestinal oncology and lymphoma oncology in the oncology department; tumor surgery includes breast surgery, head and neck surgery, thoracic surgery, tumor gynecology, and abdominal surgery.
This report aims to provide a comprehensive presentation of the global market for Interventional Oncology Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Interventional Oncology Device. This report contains market size and forecasts of Interventional Oncology Device in global, including the following market information:

• Global Interventional Oncology Device Market Revenue, 2019-2024, 2025-2030, ($ millions)
• Global Interventional Oncology Device Market Sales, 2019-2024, 2025-2030, (K Units)
• Global top five Interventional Oncology Device companies in 2023 (%)

The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Ablation Devices Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Interventional Oncology Device include AngioDynamics, Inc., BD, Boston Scientific Corporation, BTG Plc, Eckert & Ziegler BEBIG, HealthTronics, Inc., IceCure Medical, Medtronic PLC and Medwaves, Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Interventional Oncology Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Interventional Oncology Device Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Interventional Oncology Device Market Segment Percentages, by Type, 2023 (%)

• Ablation Devices
• Embolization Devices
• Supporting Devices
• Next Generation Devices

Global Interventional Oncology Device Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Interventional Oncology Device Market Segment Percentages, by Application, 2023 (%)

• Hospitals
• Specialty Clinics and Ambulatory Surgical Centers
• Others (Homecare and Research Institutes)

Global Interventional Oncology Device Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Interventional Oncology Device Market Segment Percentages, By Region and Country, 2023 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Interventional Oncology Device revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Interventional Oncology Device revenues share in global market, 2023 (%)
Key companies Interventional Oncology Device sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Interventional Oncology Device sales share in global market, 2023 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AngioDynamics, Inc.
• BD
• Boston Scientific Corporation
• BTG Plc
• Eckert & Ziegler BEBIG
• HealthTronics, Inc.
• IceCure Medical
• Medtronic PLC
• Medwaves, Inc.
• Merit Medical Systems, Inc.
• Sanarus Technologies, Inc.
• Sirtex Medical Ltd.
• Sonacare Medical
• Terumo Corporation
• Trod Medical
• Cook Meidical LLC

Outline of Major Chapters:

• Chapter 1: Introduces the definition of Interventional Oncology Device, market overview.
• Chapter 2: Global Interventional Oncology Device market size in revenue and volume.
• Chapter 3: Detailed analysis of Interventional Oncology Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
• Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
• Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
• Chapter 6: Sales of Interventional Oncology Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
• Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
• Chapter 8: Global Interventional Oncology Device capacity by region & country.
• Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
• Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
• Chapter 11: The main points and conclusions of the report.